NCT04827212

Brief Summary

This pilot study is a small sample (N=46) 16-week clinical trial with a follow-up after 24-weeks among sedentary adults \>60 y with a BMI \>25 kg/m2 to tests the impact of a hybrid artificial intelligence behavior change system (Companion) on physical activity. Participants will be randomized to a control and intervention group. All participants will engage in a proven supervised exercise program from week 1 to 16. Only the intervention group will receive Companion from week 1 to 16.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 16, 2021

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

March 23, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 1, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 2, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 13, 2022

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

July 3, 2024

Completed
Last Updated

July 3, 2024

Status Verified

June 1, 2024

Enrollment Period

1.6 years

First QC Date

March 23, 2021

Results QC Date

March 21, 2024

Last Update Submit

June 29, 2024

Conditions

Outcome Measures

Primary Outcomes (6)

  • Physical Activity Hours Per Day Measured Using a Body-worn Accelerometer at Baseline

    Total time spent being active will be measured using a body worn motion sensor (accelerometer) during waking hours over a period of one week. Measures for each day (hours) will be averaged to obtain a representative estimate of daily habitual behavior.

    Baseline

  • Physical Activity Hours Per Day Measured Using a Body-worn Accelerometer After 4 Months

    Total time spent being active will be measured using a body worn motion sensor (accelerometer) during waking hours over a period of one week. Measures for each day (hours) will be averaged to obtain a representative estimate of daily habitual behavior.

    4 months

  • Physical Activity Hours Per Day Measured Using a Body-worn Accelerometer After 6 Months

    Total time spent being active will be measured using a body worn motion sensor (accelerometer) during waking hours over a period of one week. Measures for each day (hours) will be averaged to obtain a representative estimate of daily habitual behavior.

    6 months

  • Sedentary Behavior Hours Per Day Measured Using a Body-worn Accelerometer at Baseline

    Total time spent sedentary will be measured using a body worn motion sensor (accelerometer) during waking hours over a period of one week. Measures for each day (hours) will be averaged to obtain a representative estimate of daily habitual behavior.

    Baseline

  • Sedentary Behavior Hours Per Day Measured Using a Body-worn Accelerometer After 4 Months

    Total time spent sedentary will be measured using a body worn motion sensor (accelerometer) during waking hours over a period of one week. Measures for each day (hours) will be averaged to obtain a representative estimate of daily habitual behavior.

    4 months

  • Sedentary Behavior Hours Per Day Measured Using a Body-worn Accelerometer After 6 Months

    Total time spent sedentary will be measured using a body worn motion sensor (accelerometer) during waking hours over a period of one week. Measures for each day (hours) will be averaged to obtain a representative estimate of daily habitual behavior.

    6 months

Other Outcomes (18)

  • Percent Body Fat Measured Via Bioelectrical Impedance at Baseline

    Baseline

  • Percent Body Fat Measured Via Bioelectrical Impedance After 4 Months

    4 months

  • Percent Body Fat Measured Via Bioelectrical Impedance After 6 Months

    6 months

  • +15 more other outcomes

Study Arms (2)

Control

NO INTERVENTION

Control group will engage in a 16-week supervised exercise program and then be followed-up after 24 weeks

Treatment

EXPERIMENTAL

Treatment group will engage in a 16-week supervised exercise program and then be followed-up after 24 weeks. In addition, the Companion will be deployed in the treatment group only.

Behavioral: Companion

Interventions

CompanionBEHAVIORAL

Companion integrates wearable sensing with the smartphone to develop a behavior-aware, virtual system that uses a "human-in-the-loop" approach to enable meaningful two-way communication. Companion builds rich models of typical behavior using sensors and context sensitive ecological momentary assessment to deliver intervention components and behavior change strategies using socially engaging, contextually salient, and tailored text-message conversations in near-real-time.

Treatment

Eligibility Criteria

Age60 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 60 years and above- This intervention study focusses on this population demographic.
  • Participants have a body mass index greater than 25 kg/m2- This threshold for BMI is used to classify an adult as overweight or obese
  • No conditions preventing participation in physical activity lasting 10 to 30 min- Such conditions will limit prescription of physical activity/exercise components of the training program and that promoted using Companion.
  • Have a smart phone- The absence of a smart phone will limit the ability of remote communication with the study participant using Companion.

You may not qualify if:

  • Engage in structured physical activity for more than 2 days/week lasting 30 min/session- Physically active participants will not be representative of typical adults \>60 y. Being active prior to study participation may mask the effects of the intervention.
  • Regularly use any assistive device for walking- Use of an assistive device would limit the ability to engage in prescribed physical activity. Future work can be tailored for sub-groups in the demographic being studied.
  • Likely to alter medications pertaining to cardiovascular or metabolic health- Altering medications during the study will influence change in selected outcome measures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northeastern Univeristy

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Results Point of Contact

Title
Dr. Dinesh John
Organization
Northeastern University

Study Officials

  • Dinesh John, PhD

    Northeastern University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 23, 2021

First Posted

April 1, 2021

Study Start

March 16, 2021

Primary Completion

November 2, 2022

Study Completion

December 13, 2022

Last Updated

July 3, 2024

Results First Posted

July 3, 2024

Record last verified: 2024-06

Locations